In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.
Where this comes from
- Record sourced from PubMed, PMID 32539517.
- Also identified by DOI 10.7326/ACPJ202006160-065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Solomon SD, Vaduganathan M, Claggett BL, et al. <b>Sacubitril/valsartan across the spectrum of ejection fraction in heart failure.</b> Circulation. 2020;141:352-61. 31736342.
Medical subject headings
- Angiotensin Receptor Antagonists
- Heart Failure